Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
138M
-
Number of holders
-
263
-
Total 13F shares, excl. options
-
161M
-
Shares change
-
+24.8M
-
Total reported value, excl. options
-
$7.01B
-
Value change
-
+$1.16B
-
Put/Call ratio
-
0.43
-
Number of buys
-
185
-
Number of sells
-
-70
-
Price
-
$43.57
Significant Holders of Avidity Biosciences, Inc. - COMMON STOCK (RNA) as of Q3 2025
301 filings reported holding RNA - Avidity Biosciences, Inc. - COMMON STOCK as of Q3 2025.
Avidity Biosciences, Inc. - COMMON STOCK (RNA) has 263 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 161M shares
.
Largest 10 shareholders include FMR LLC (21.6M shares), JANUS HENDERSON GROUP PLC (14.5M shares), VANGUARD GROUP INC (13.2M shares), RTW INVESTMENTS, LP (11.4M shares), WELLINGTON MANAGEMENT GROUP LLP (10.1M shares), PRICE T ROWE ASSOCIATES INC /MD/ (9.79M shares), BlackRock, Inc. (9.2M shares), RA CAPITAL MANAGEMENT, L.P. (8.64M shares), Avoro Capital Advisors LLC (7.65M shares), and STATE STREET CORP (4.89M shares).
This table shows the top 263 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.